Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A recent case report by Humphrey in the Journal of Urology offers information about a 67-year-old patient found to have a form of prostate cancer known as angiosarcoma of the prostate.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: angiosarcoma, primary, sarcoma | 4 Comments »
Many patients with no specific evidence of metastatic disease now receive primary androgen deprivation therapy (PADT) much earlier than was the case before the availability of the PSA test. This includes patients who get hormone therapy for a rising PSA after other forms of first-line therapy and patients who receive hormone therapy as their first-line [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, hormone therapy, primary | 4 Comments »
Today’s news reports cover such items as: Identification of prostate cancer cells in urine Prognosis after radiation therapy The effect of bisphenol A on prostate cancer therapy The appropriateness of primary androgen deprivation for localized prostate cancer Data from clinical trials of Phase II clinical trial of docetaxel + samarium-153 lexidronam and cyclophosphamide + dexamethasone [...]
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, androgen deprivation therapy, bisphenol A, cyclophosphamide, Diagnosis, docetaxel, primary, prognosis, risk, samarium-153 | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site